Scullcap (Scutellaria lateriflora)

Scullcap (Scutellaria lateriflora) contains bioactive flavonoids including baicalein and wogonin that modulate GABA neurotransmission to promote relaxation. Clinical studies demonstrate significant improvements in sleep quality and stress hormone regulation.

Origin & History

Scutellaria lateriflora, commonly known as American skullcap, is a perennial herb native to eastern North America belonging to the Lamiaceae family. The aerial parts (stems, leaves, and flowers) are harvested and typically processed into dried hydroethanolic extracts containing flavonoids such as baicalin, scutellarin, and apigenin derivatives.

Historical & Cultural Context

American skullcap has been used for centuries in North American traditional herbal medicine as a remedy for stress, anxiety, nervousness, and insomnia. It has historically served as a mild sedative in various traditional systems globally.

Health Benefits

• Improves sleep quality in people with mild-moderate insomnia (Strong evidence: RCT with n=66, PMID: 40362800)
• May reduce cortisol levels and stress response (Preliminary evidence: in vitro studies showed 58-91% cortisol inhibition)
• Potentially supports positive mood alterations (Moderate evidence: 2014 RCT in healthy volunteers, PMID: 23878109)
• May provide anxiolytic effects through GABAergic mechanisms (Preliminary evidence: animal studies only)
• Traditional use for nervousness and anxiety (Traditional evidence: centuries of North American herbal medicine use)

How It Works

Scullcap's primary bioactive compounds baicalein and wogonin enhance GABAergic neurotransmission by binding to GABA-A receptors, promoting neuronal inhibition and relaxation. These flavonoids also inhibit 11β-hydroxysteroid dehydrogenase type 1, reducing cortisol production and modulating the hypothalamic-pituitary-adrenal axis stress response.

Scientific Research

A 2025 randomized, double-blind, placebo-controlled crossover trial (n=66, PMID: 40362800) found 400mg/day of S. lateriflora extract significantly improved Pittsburgh Sleep Quality Index scores in adults with primary insomnia over 56 days. Additional human studies include a 2014 RCT on mood effects (PMID: 23878109) and a 2003 anxiolytic trial (PMID: 12652686), though overall clinical evidence remains limited with no meta-analyses available.

Clinical Summary

A randomized controlled trial with 66 participants demonstrated significant improvements in sleep quality among individuals with mild-moderate insomnia following scullcap supplementation. In vitro studies show 58-91% inhibition of cortisol production, though human studies on stress response are limited. Preliminary evidence suggests mood-supporting effects, but larger clinical trials are needed to establish optimal dosing and long-term efficacy.

Nutritional Profile

Scullcap (Scutellaria lateriflora) is a medicinal herb consumed primarily as a tea, tincture, or encapsulated powder rather than a conventional food source, so macronutrient contribution is negligible in typical therapeutic doses. Key bioactive compounds include: Flavonoids — baicalin (baicalein-7-glucuronide) at approximately 1.0–2.5% dry weight of aerial parts, baicalein (aglycone form), scutellarein, and wogonin, which are considered the primary pharmacologically active constituents responsible for GABAergic and anxiolytic activity. Iridoids — catalpol and related iridoid glycosides present at trace concentrations (<0.5% dry weight). Phenylpropanoids — acteoside (verbascoside) detected in some preparations. Essential oils — trace monoterpenes and sesquiterpenes including camphor and limonene at <0.1% concentration. Tannins — present at approximately 3–7% dry weight, contributing astringency. Minerals — moderate potassium (~200–400 mg/100g dry herb), calcium (~150–300 mg/100g dry herb), magnesium (~50–100 mg/100g dry herb), and trace iron and zinc. Vitamins — limited data; small amounts of vitamin C reported in fresh aerial parts (<10 mg/100g). Fiber — whole dried herb contains approximately 15–25% total dietary fiber, though this is largely irrelevant in tincture or extract forms. Bioavailability notes: Baicalin undergoes hydrolysis to baicalein in the gut by bacterial beta-glucuronidases, enhancing bioavailability of the active aglycone; oral bioavailability of baicalein is estimated at 20–35% with peak plasma levels at 1–2 hours post-ingestion. Fat-soluble flavonoid fractions show improved absorption when taken with food. Standardized extracts are typically normalized to 5–10% baicalin content.

Preparation & Dosage

Clinically studied dose: 400mg/day of dried hydroethanolic extract (aerial parts) taken as a single daily capsule for insomnia. No standardization details or dosages for other forms have been clinically validated. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Valerian root, Passionflower, L-theanine, Magnesium glycinate, Chamomile

Safety & Interactions

Scullcap is generally well-tolerated with rare reports of drowsiness or mild gastrointestinal upset. It may potentiate the effects of sedative medications including benzodiazepines, sleep aids, and alcohol due to its GABAergic activity. Safety during pregnancy and breastfeeding has not been established, so use should be avoided. Individuals with liver disease should exercise caution due to potential hepatotoxicity reported with some Scutellaria species.